Kymera Therapeutics, Inc. KYMR
6 trading plans running, 67 Form 144 notices for $489.7M
10-Q, 10-K and Form 144What KYMR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Sep 20, 2024 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Nello Mainolfi Founder, President, Chief Executive Officer |
Adopted 10b5-1 plan | Mar 24, 2026 | 10-Q Apr 30, 2026 |
| Bruce Jacobs Chief Financial Officer |
Adopted 10b5-1 plan | Mar 23, 2026 | 10-Q Apr 30, 2026 |
| Bruce Booth Director |
Adopted 10b5-1 plan | Dec 16, 2025 | 10-K Feb 26, 2026 |
| Elena Ridloff Director |
Adopted 10b5-1 plan | Dec 11, 2025 | 10-K Feb 26, 2026 |
| Jeremy Chadwick Chief Operating Officer |
Adopted 10b5-1 plan | Dec 10, 2025 | 10-K Feb 26, 2026 |
| Noah Goodman Chief Business Officer |
Adopted 10b5-1 plan | Dec 10, 2025 | 10-K Feb 26, 2026 |
| Pamela Esposito Director |
Adopted 10b5-1 plan | Sep 17, 2025 | 10-Q Nov 4, 2025 |
| Jared Gollob Chief Medical Officer |
Adopted 10b5-1 plan | Jun 2, 2025 | 10-Q Aug 11, 2025 |
| Elena Ridloff Director |
Adopted 10b5-1 plan | Nov 25, 2024 | 10-K Feb 27, 2025 |
| Jeffrey Albers Director |
Adopted 10b5-1 plan | Sep 20, 2024 | 10-Q Oct 31, 2024 |
| Bruce Jacobs Chief Financial Officer |
Adopted 10b5-1 plan | Sep 6, 2024 | 10-Q Oct 31, 2024 |
| Nello Mainolfi Founder, President, Chief Executive Officer |
Adopted 10b5-1 plan | Sep 6, 2024 | 10-Q Oct 31, 2024 |
| Pamela Esposito Director |
Adopted 10b5-1 plan | Jun 18, 2024 | 10-Q Aug 7, 2024 |
| Bruce Jacobs Chief Financial Officer |
Ended 10b5-1 plan | Dec 22, 2023 | 10-K Feb 22, 2024 |
| Nello Mainolfi Founder, President, Chief Executive Officer |
Ended 10b5-1 plan | Dec 20, 2023 | 10-K Feb 22, 2024 |
Show the other 7 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 1, 2026 | Mainolfi Nello Officer, Director |
30,000 | $3.4M |
| Sep 4, 2026 | Brian Adams Officer |
6,371 | $747K |
| Sep 2, 2026 | JEREMY CHADWICK Officer |
10,879 | $1.3M |
| Jul 7, 2026 | Mainolfi Nello Officer, Director |
50,000 | $6.0M |
| Jul 2, 2026 | Mainolfi Nello Officer, Director |
80,000 | $9.1M |
| Jul 1, 2026 | NOAH GOODMAN Officer |
3,389 | $389K |
| Jun 30, 2026 | BRUCE N. JACOBS Officer |
77,109 | $8.4M |
| Jun 29, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
10,473 | $1.1M |
| Jun 29, 2026 | Atlas Venture Fund X, LP Shareholder |
66,177 | $7.2M |
| Jun 26, 2026 | Atlas Venture Fund X, LP Shareholder |
410,427 | $47.8M |
| Jun 26, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
57,451 | $6.7M |
| Jun 26, 2026 | BVF PARTNERS L P/IL Affiliate of Director |
1,630,658 | $189.9M |
| Jun 25, 2026 | NOAH GOODMAN Officer |
5,000 | $499K |
| Jun 25, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
67,329 | $6.7M |
| Jun 25, 2026 | Atlas Venture Fund X, LP Shareholder |
480,992 | $48.0M |
| Jun 24, 2026 | Atlas Venture Fund X, LP Shareholder |
118,178 | $11.6M |
| Jun 24, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
16,542 | $1.6M |
| Jun 23, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
173 | $17K |
| Jun 23, 2026 | Atlas Venture Fund X, LP Shareholder |
1,235 | $123K |
| Jun 22, 2026 | NOAH GOODMAN Officer |
2,500 | $226K |
| Jun 22, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
34,152 | $3.1M |
| Jun 22, 2026 | Atlas Venture Fund X, LP Shareholder |
243,976 | $22.1M |
| Jun 18, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
14,128 | $1.3M |
| Jun 18, 2026 | Atlas Venture Fund X, LP Shareholder |
100,928 | $9.1M |
| Jun 17, 2026 | JEREMY CHADWICK Officer |
66,893 | $5.8M |
| Jun 17, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
12,902 | $1.1M |
| Jun 17, 2026 | Atlas Venture Fund X, LP Shareholder |
92,169 | $8.1M |
| Jun 17, 2026 | Bruce Booth Director |
11,741 | $1.0M |
| May 26, 2026 | JEREMY CHADWICK Officer |
13,130 | $1.0M |
| May 26, 2026 | Chadwick Jeremy G Officer |
4,054 | $318K |
| May 11, 2026 | ELENA RIDLOFF Director |
3,000 | $258K |
| Apr 29, 2026 | Mainolfi Nello Officer, Director |
30,000 | $2.5M |
| Apr 22, 2026 | JEREMY CHADWICK Officer |
300 | $26K |
| Apr 22, 2026 | Atlas Venture Fund X, LP Shareholder |
88 | $8K |
| Apr 22, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
12 | $1K |
| Apr 15, 2026 | JEREMY CHADWICK Officer |
1,300 | $117K |
| Apr 15, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
385 | $35K |
| Apr 15, 2026 | Atlas Venture Fund X, LP Shareholder |
2,750 | $247K |
| Apr 14, 2026 | JEREMY CHADWICK Officer |
5,251 | $465K |
| Apr 14, 2026 | Bruce Booth Director |
24,000 | $2.1M |
| Apr 9, 2026 | Noah Goodman Officer |
11,611 | $1.0M |
| Apr 1, 2026 | ELENA RIDLOFF Director |
4,600 | $383K |
| Apr 1, 2026 | JEREMY CHADWICK Officer |
14,640 | $1.2M |
| Mar 31, 2026 | JEREMY CHADWICK Officer |
7,600 | $604K |
| Mar 31, 2026 | ELENA RIDLOFF Director |
7,400 | $588K |
| Mar 23, 2026 | JEREMY CHADWICK Officer |
115,977 | $9.0M |
| Mar 20, 2026 | PAMELA ESPOSITO Director |
2,500 | $199K |
| Mar 11, 2026 | JEREMY CHADWICK Officer |
25,758 | $2.2M |
| Mar 2, 2026 | Atlas Venture Opportunity Fund I, LP Shareholder |
25,000 | $2.3M |
| Mar 2, 2026 | Atlas Venture Fund X, LP Shareholder |
200,000 | $18.3M |
| Mar 2, 2026 | Gollob Jared Officer |
10,613 | $956K |
| Mar 2, 2026 | Chadwick Jeremy G Officer |
6,206 | $559K |
| Mar 2, 2026 | Jacobs Bruce N. Officer |
12,576 | $1.1M |
| Feb 25, 2026 | Mainolfi Nello Officer, Director |
30,000 | $2.7M |
| Feb 20, 2026 | PAMELA ESPOSITO Director |
2,500 | $216K |
| Jan 20, 2026 | PAMELA ESPOSITO Director |
5,500 | $382K |
| Dec 31, 2025 | Mainolfi Nello Officer, Director |
30,000 | $2.3M |
| Dec 17, 2025 | PAMELA ESPOSITO Director |
27,563 | $2.3M |
| Dec 12, 2025 | Atlas Venture Opportunity Fund I, L.P. Director |
108 | $10K |
| Dec 12, 2025 | Atlas Venture Fund X, L.P. Director |
570 | $51K |
| Dec 11, 2025 | Atlas Venture Opportunity Fund I, L.P. Director |
976 | $86K |
| Dec 11, 2025 | Atlas Venture Fund X, L.P. Director |
5,125 | $450K |
| Dec 10, 2025 | Atlas Venture Opportunity Fund I, L.P. Director |
36,769 | $3.3M |
| Dec 10, 2025 | Atlas Venture Fund X, L.P. Director |
193,040 | $17.4M |
| Dec 8, 2025 | Mainolfi Nello Officer, Director |
100,000 | $8.9M |
| Dec 8, 2025 | Jared Gollob Officer |
49,307 | $3.3M |
| Dec 8, 2025 | JEFFREY ALBERS Director |
5,000 | $333K |
Show the other 59 notices
From the Form 144 XML filed with the SEC, since Dec 8, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KYMR/export.csv") into a cell.